PET显像在转移性前列腺癌患者中的临床影响
本文为 pictorial essay,展示一系列转移性前列腺癌患者的多种放射性示踪剂PET图像,讨论PET/CT在前列腺癌管理中的临床作用;文中指出Ga-前列腺特异性膜抗原灵敏度与特异度最高,F-FDG和Ga-DOTATATE在PSMA阴性(如神经内分泌分化)患者中仍有作用。
要点
- PET/CT因更高的灵敏度和特异度已成为前列腺癌管理不可或缺的部分。
- Ga-前列腺特异性膜抗原(PSMA)提供最高的灵敏度与特异度。
- F-FDG和Ga-DOTATATE在PSMA阴性(如神经内分泌分化)前列腺癌患者中仍有作用。
核心结论
- PET/CT因更高的灵敏度和特异度已成为前列腺癌管理不可或缺的部分。
- Ga-PSMA提供最高的灵敏度与特异度,F-FDG和Ga-DOTATATE在PSMA阴性(如神经内分泌分化)患者中仍有作用。
研究设计与样本
- 本文为 pictorial essay,展示一系列转移性前列腺癌患者使用不同放射性示踪剂的PET图像。
主要发现
- 用于PET显像的放射性示踪剂显示疾病过程的不同分子层面。
- Ga-前列腺特异性膜抗原(PSMA)提供最高的灵敏度与特异度。
- F-FDG和Ga-DOTATATE在前列腺特异性膜抗原阴性(如伴神经内分泌分化的前列腺癌)患者中仍有作用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Prostate cancer (Pca) is the most common cancer and the second leading cause of death among men. Although conventional bone scans and abdominal CT are preferred in most of the guidelines and clinical trials, PET/CT has already started to become the inevitable part of Pca management because of its higher sensitivity and specificity. Radiotracers used for PET imaging show different molecular aspects of the disease process. Although Ga-prostate-specific membrane antigen offers the highest sensitivity and specificity, other PET radiotracers such as F-FDG and Ga-DOTATATE still have a role in patients with prostate-specific membrane antigen-negative diseases such as Pca with neuroendocrine differentiation. In this pictorial essay, we have presented a series of patients with metastatic Pca who had PET images with different radiotracers and discussed the clinical role of this imaging modality in patient management.
引用
- Tuncel M, Tuncalı MÇ, Telli T, et al. Clinical Impact of PET Imaging in Patients With Metastatic Prostate Cancer. Clin Nucl Med. 2020. PMID: 32701793. doi:10.1097/RLU.0000000000003126
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。